Project Summary/Abstract
Extensive research has confirmed that cigarettes marketed as “light,” “low tar,” and “mild” were misperceived
as having lower risks and in recognition of this, the 2009 Tobacco Control Act (TCA) banned the use of these
descriptors in one of its earliest regulatory actions, but did not address other misleading terms that studies
have shown also suggest reduced harm for products utilizing them. One of these products is Natural American
Spirit (NAS), a heavily advertised and top selling premium cigarette brand popular among young adults that
promotes itself to consumers using the terms “additive free,” “natural,” and “organic.” The FDA has taken steps
to stop NAS from using the misleading product descriptors “natural” and “additive-free” but the issue remains
unsettled. The proposed research project aims to provide additional scientific evidence on the terms “natural,”
“additive-free,” and “organic,” use of the claim “natural” as part of the brand name, and the use of written
claims that may imply the product is “natural” and “additive-free” (e.g., “ingredients: tobacco and water”).
Specifically, we aim to 1) understand consumer perceptions of the NAS brand name, descriptors (e.g,
“organic”, “Tobacco Ingredients: Tobacco and Water”), and imagery in NAS advertising by conducting twelve
focus groups with young adult (ages 18-24) smokers and nonsmokers, 2) assess the effect of such descriptors
in print advertising on cigarette risk perceptions and use intentions among 2400 young adult (18-24) smokers
and non-smokers using a between-subjects online experiment, and 3) examine population differences in
tobacco perceptions, use intentions, and use between NAS and other brand (OB) smokers, comparing them
over time via longitudinal analysis of the Population Assessment of Tobacco and Health (PATH) survey study.
Lastly, a secondary aim will be to monitor claims and images used in NAS cigarette advertising with a
longitudinal content analysis of NAS print and direct mail advertising using data from our TCORS Tobacco
Industry Marketing Core. Overall, this research will fit under the UPENN/Rutgers TCORS Integrative Theme of
marketing, advertising and packaging of combusted tobacco products, and will directly address the FDA
Center for Tobacco Products Scientific Domains of Marketing Influences and Behavior. The findings from this
study will build and advance the evidence base on the impact of misleading terms implying reduced risk to
assist the FDA in overcoming legal challenges and/or expanding restrictions on descriptors. By providing
research on consumers' meanings and attitudes towards these claims, our findings may also inform tobacco
control counter-marketing efforts aimed at reducing their influence.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdvertisingAffectAgeAmericanAttitudeBehaviorBehavioralCigaretteDataDescriptorDropsFocus GroupsHealthHealth SurveysImageImageryIntentionLabelLegalLettersLightMarketingMethodsMonitorNamesPerceptionPoliciesPopulationPopulation Assessment of Tobacco and HealthRecording of previous eventsRegulationRelative RisksResearchResearch Project GrantsRiskSmokerSmokingTarsTestingTimeTobaccoTobacco IndustryTobacco useWaterWorkauthoritycigarette advertisingdemographicsdesignevidence baseexperimental studylongitudinal analysisnon-smokerresponserisk perceptiontobacco advertisingtobacco controltobacco productstobacco regulatory sciencetobacco tartrendyoung adult
No Sub Projects information available for 5U54CA229973-03 6929
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U54CA229973-03 6929
Patents
No Patents information available for 5U54CA229973-03 6929
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U54CA229973-03 6929
Clinical Studies
No Clinical Studies information available for 5U54CA229973-03 6929
News and More
Related News Releases
No news release information available for 5U54CA229973-03 6929
History
No Historical information available for 5U54CA229973-03 6929
Similar Projects
No Similar Projects information available for 5U54CA229973-03 6929